Does VALSARTAN Cause Ventricular hypertrophy? 29 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Ventricular hypertrophy have been filed in association with VALSARTAN (valsartan). This represents 0.1% of all adverse event reports for VALSARTAN.
29
Reports of Ventricular hypertrophy with VALSARTAN
0.1%
of all VALSARTAN reports
16
Deaths
29
Hospitalizations
How Dangerous Is Ventricular hypertrophy From VALSARTAN?
Of the 29 reports, 16 (55.2%) resulted in death, 29 (100.0%) required hospitalization, and 12 (41.4%) were considered life-threatening.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (20)
Which VALSARTAN Alternatives Have Lower Ventricular hypertrophy Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL